| For: | Lv Y, Luo WJ. Dapagliflozin and sacubitril on myocardial microperfusion in patients with post-acute myocardial infarction heart failure and type 2 diabetes. World J Clin Cases 2024; 12(22): 5008-5015 [PMID: 39109007 DOI: 10.12998/wjcc.v12.i22.5008] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i22/5008.htm |
| Number | Citing Articles |
| 1 |
Dong-Hua Liu, Xiao-Ming Dong, Wen-Jie Long. Advancing cardiovascular outcomes with dapagliflozin and sacubitril in post-acute myocardial infarction heart failure and type 2 diabetes mellitus. World Journal of Clinical Cases 2024; 12(36): 6935-6938 doi: 10.12998/wjcc.v12.i36.6935
Abstract(485) |
Core Tip(484) |
Full Article(HTML)(1962)
|
Full Article with Cover (PDF)-582K(113)
|
Full Article (Word)-22K(7)
|
Audio-410K(8)
|
Peer-Review Report-236K(92)
|
Answering Reviewers-71K(96)
|
Full Article (PDF)-343K(142)
|
Full Article (XML)-51K(102)
|
Times Cited (2)
|
Total Visits (4794)
|
Open
|
| 2 |
Jianwen Wen, Jiebin Huang, Quan Sun, Wei Ding. Development and validation of a nomogram model incorporating serum GDF-15, MEG3, and HSP-70 for predicting short-term outcomes in patients with acute myocardial infarction: a retrospective study. European Journal of Medical Research 2026; doi: 10.1186/s40001-026-04224-z
|
